Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study.

Yan ZhangJing-Lu JinYe-Xuan CaoHui-Wen ZhangYuan-Lin GuoNa-Qiong WuCheng-Gang ZhuYing GaoQi HuaYan-Fang LiRui-Xia XuJian-Jun Li

Published in: Cardiovascular diabetology (2020)

Our data, for the first time, confirmed that Lp(a) was an independent predictor for recurrent CVEs in T2DM patients with prior CVEs, suggesting that Lp(a) measurement may help to further risk stratification for T2DM patients after they suffered a first CVE.

Keyphrases

cardiovascular events
end stage renal disease
coronary artery disease
ejection fraction
newly diagnosed
cardiovascular disease
chronic kidney disease
peritoneal dialysis
glycemic control
electronic health record
machine learning
deep learning